Prognosis of COPD patients requiring frequent hospitalization: Role of airway infection

Respiratory Medicine

Volumn 104, Issue 6, 2010, Pages 840-848

  Renom, Feliu ^a   Yáñez, Aina ^b   Garau, Margarita ^c   Rubí, Mateu ^a   Centeno, Maria José ^a   Gorriz, Maria Teresa ^a   Medinas, Magdalena ^a   Ramis, Ferran ^a   Soriano, Joan B ^b,d   Alvar Agusti ^d,e  

^a Hospital Joan March   (Spain)

^b Program of Epidemiology and Clinical Research   (Spain)

^c HOSPITAL SON LLÀTZER   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e HOSPITAL CLÍNIC   (Spain)

Author keywords

Airway infection; BODE index; Chronic obstructive; Microbiology; Mortality; Pulmonary disease

Indexed keywords

ANTIBIOTIC AGENT; METICILLIN;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTION; FEMALE; FOLLOW UP; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROORGANISM; MORTALITY; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTION; RESPIRATORY TRACT INFECTION; SPIROMETRY; SPUTUM CULTURE; WALKING; DISEASE COURSE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PATHOGENICITY; PATHOPHYSIOLOGY; RECURRENT DISEASE; SPUTUM; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECURRENCE; SPUTUM;

EID: 77952419414     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2009.12.010     Document Type: Article

References (48)

1. Connors Jr. A.F., Dawson N.V., Thomas C., et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments). Am J Respir Crit Care Med 154 (1996) 959-967
2. Soler-Cataluna J.J., Martinez-Garcia M.A., Roman S.P., et al. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 60 (2005) 925-931
3. Miravitlles M., Murio C., Guerrero T., et al. Costs of chronic bronchitis and COPD: a 1-year follow-up study. Chest 123 (2003) 784-791
4. Strassels S.A., Smith D.H., Sullivan S.D., et al. The costs of treating COPD in the United States. Chest 119 (2001) 344-352
5. Sullivan S.D., Ramsey S.D., and Lee T.A. The economic burden of COPD. Chest 117 (2000) 5S-9S
6. Papi A., Bellettato C.M., Braccioni F., et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 173 (2006) 1114-1121
7. Sethi S., and Murphy T.F. Infection in the Pathogenesis and Course of Chronic Obstructive Pulmonary Disease. N Engl J Med 359 (2008) 2355-2365
8. Soler J., Sanchez L., Latorre M., et al. [The impact of COPD on hospital resources: the specific burden of COPD patients with high rates of hospitalization]. Arch Bronconeumol 37 (2001) 375-381
9. Clini E., Vitacca M., Foglio K., et al. Long-term home care programmes may reduce hospital admissions in COPD with chronic hypercapnia. Eur Respir J 9 (1996) 1605-1610
10. Guell R., Gonzalez A., Morante F., et al. [Better at home: a continuous health care program for patients with advanced chronic respiratory disease]. Arch Bronconeumol 34 (1998) 541-546
11. Casas A., Troosters T., Garcia-Aymerich J., et al. Integrated care prevents hospitalisations for exacerbations in COPD patients. Eur Respir J 28 (2006) 123-130
12. Rea H., McAuley S., Stewart A., et al. A chronic disease management programme can reduce days in hospital for patients with chronic obstructive pulmonary disease. Intern Med J 34 (2004) 608-614
13. Rabe K.F., Hurd S., Anzueto A., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176 (2007) 532-555
14. Mahler D.A., and Wells C.K. Evaluation of clinical methods for rating dyspnea. Chest 93 (1988) 580-586
15. Charlson M.E., Pompei P., Ales K.L., et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40 (1987) 373-383
16. Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir. Crit Care Med 152 (1995) 1107-1136
17. Roca J., Sanchis J., Agusti-Vidal A., et al. Spirometric reference values from a Mediterranean population. Bull Eur Physiopathol Respir 22 (1986) 217-224
18. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 166 (2002) 111-117
19. Celli B.R., Cote C.G., Marin J.M., et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350 (2004) 1005-1012
20. Anthonisen N.R., Manfreda J., Warren C.P., et al. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Intern Med 106 (1987) 196-204
21. Murray P.R., and Washington J.A. Microscopic and bacteriologic analysis of expectorated sputum. Mayo Clin Proc 50 (1975) 339-344
22. Murray P.R., Baron E.J., Jorgensen J.H., et al. Manual of clinical microbiology. 8th ed. (2003), American Society for Microbiology, Washington, DC
23. Barrow G.I., and Feltham R.K. Cowan and Steel's manual for the identification of medical bacteria. 3rd ed. (1993), Cambridge University Press, Cambridge
24. Wayne P.A. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically. NCCLS approved standard M7-A6 (2003), NCCLS
25. Eller J., Ede A., Schaberg T., et al. Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function. Chest 113 (1998) 1542-1548
26. Groenewegen K.H., and Wouters E.F. Bacterial infections in patients requiring admission for an acute exacerbation of COPD; a 1-year prospective study. Respir Med 97 (2003) 770-777
27. Miravitlles M. Exacerbations of chronic obstructive pulmonary disease: when are bacteria important?. Eur Respir J Suppl 36 (2002) 9s-19s
28. Rosell A., Monso E., Soler N., et al. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. Arch Intern Med 165 (2005) 891-897
29. Soler N., Torres A., Ewig S., et al. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med 157 (1998) 1498-1505
30. Hosmer D.W., and Lemeshow S. Extensions of the proportional hazards model. Applied Survival analysis: regression modeling of time to event data (1999), Jonh Wiley and Sons, New York
31. Hosmer DW, Lemeshow S. Extensions of the proportional hazards model: Stata Texbook Examples. Date last updated; 2009 [accessed: 12.01.08].
32. Almagro P., Barreiro B., Ochoa de E.A., et al. Risk factors for hospital readmission in patients with chronic obstructive pulmonary disease. Respiration 73 (2006) 311-317
33. Garcia-Aymerich J., Monso E., Marrades R.M., et al. Risk factors for hospitalization for a chronic obstructive pulmonary disease exacerbation. EFRAM study. Am J Respir Crit Care Med 164 (2001) 1002-1007
34. Kessler R., Faller M., Fourgaut G., et al. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 159 (1999) 158-164
35. Miravitlles M., Guerrero T., Mayordomo C., et al. Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. The EOLO Study Group. Respiration 67 (2000) 495-501
36. Decramer M., Gosselink R., Troosters T., et al. Muscle weakness is related to utilization of health care resources in COPD patients. Eur Respir J 10 (1997) 417-423
37. Cao Z., Ong K.C., Eng P., et al. Frequent hospital readmissions for acute exacerbation of COPD and their associated factors. Respirology 11 (2006) 188-195
38. Lin S.H., Kuo P.H., Hsueh P.R., et al. Sputum bacteriology in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease in Taiwan with an emphasis on Klebsiella pneumoniae and Pseudomonas aeruginosa. Respirology 12 (2007) 81-87
39. Miravitlles M., Espinosa C., Fernandez-Laso E., et al. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Study Group of Bacterial Infection in COPD. Chest 116 (1999) 40-46
40. Nseir S., Di P.C., Cavestri B., Jozefowicz E., et al. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: prevalence, risk factors, and outcome. Crit Care Med 34 (2006) 2959-2966
41. Patel I.S., Seemungal T.A., Wilks M., et al. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax 57 (2002) 759-764
42. Canton R., Cobos N., de Gracia J., et al. Antimicrobial therapy for pulmonary pathogenic colonisation and infection by Pseudomonas aeruginosa in cystic fibrosis patients. Clin Microbiol Infect 11 (2005) 690-703
43. Vendrell M. Diagnóstico y tratamiento de las bronquiectasias. Recomendaciones SEPAR. 51 (2008), Elsevier España SL
44. Otsuka Y., Ohkusu K., Kawamura Y., et al. Emergence of multidrug-resistant Corynebacterium striatum as a nosocomial pathogen in long-term hospitalized patients with underlying diseases. Diagn Microbiol Infect Dis 54 (2006) 109-114
45. Renom F., Garau M., Rubi M., et al. Nosocomial outbreak of Corynebacterium striatum infection in patients with chronic obstructive pulmonary disease. J Clin Microbiol 45 (2007) 2064-2067
46. Emerson J., Rosenfeld M., McNamara S., et al. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol 34 (2002) 91-100
47. Murphy T.F., Brauer A.L., Eschberger K., et al. Pseudomonas aeruginosa in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 177 (2008) 853-860
48. Patel I.S., Vlahos I., Wilkinson T.M., et al. Bronchiectasis, exacerbation indices, and inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 170 (2004) 400-407